1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Contraceptives-Pipeline Insights, 2014

Contraceptives-Pipeline Insights, 2014

  • August 2014
  • -
  • Delve Insight

SUMMARY
DelveInsight’s,“ Contraceptives-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Contraceptives. This report provides information on the therapeutic development based on the Contraceptives dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Contraceptives
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Contraceptives pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Contraceptives and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Contraceptives
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Contraceptives pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table Of Contents

Contraceptives-Pipeline Insights, 2014
Table of Contents
- Contraceptives Overview
- Contraceptives Pipeline Therapeutics
- Contraceptives Therapeutics under Development by Companies
- Contraceptives Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Contraceptives Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Contraceptives Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Contraceptives Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Contraceptives - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Contraceptives - Discontinued Products
- Contraceptives - Dormant Products
- Companies Involved in Therapeutics Development for Contraceptives
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Contraceptives, 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Contraceptives Assessment by Monotherapy Products
- Contraceptives Assessment by Combination Products
- Contraceptives Assessment by Route of Administration
- Contraceptives Assessment by Stage and Route of Administration
- Contraceptives Assessment by Molecule Type
- Contraceptives Assessment by Stage and Molecule Type
- Contraceptives Therapeutics - Discontinued Products
- Contraceptives Therapeutics - Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Contraceptives, 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Contraceptives Assessment by Monotherapy Products
- Contraceptives Assessment by Combination Products
- Contraceptives Assessment by Route of Administration
- Contraceptives Assessment by Stage and Route of Administration
- Contraceptives Assessment by Molecule Type
- Contraceptives Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Contraceptives - Consumer Healthcare

Global Contraceptives - Consumer Healthcare

  • $ 4950
  • Industry report
  • January 2017
  • by Global Industry Analysts

This report analyzes the worldwide markets for Contraceptives in US$ by the following Contraception Methods: Hormonal Contraceptives (Oral Contraceptives, & Other Hormonal Contraceptives), and Condoms. ...

Global Contraceptive Sponges Market 2017-2021

Global Contraceptive Sponges Market 2017-2021

  • $ 3500
  • Industry report
  • January 2017
  • by Infiniti Research Limited

About Contraceptive Sponges Contraceptive sponges are soft foam sponges with or without spermicide. These sponges are placed inside the vagina to cover the cervix, before intercourse. They absorb and disable ...

Global Hormonal Contraception Market Research Report 2016

Global Hormonal Contraception Market Research Report 2016

  • $ 2850
  • Industry report
  • November 2016
  • by 9Dimen Research

2016 Global Hormonal Contraception Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Hormonal Contraception industry, focusing on the ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in China

  • February 2017
    8 pages
  • Therapy  

    Contraceptive  

  • China  

View report >

Contraceptive Market in the Netherlands

  • February 2017
    8 pages
  • Contraceptive  

  • Netherlands  

View report >

Cytokine Industry in the US

  • February 2017
    12 pages
  • Cytokine  

    Hormone  

  • United States  

View report >

Related Market Segments :

Contraceptive

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.